vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and PEOPLES BANCORP OF NORTH CAROLINA INC (PEBK). Click either name above to swap in a different company.
PEOPLES BANCORP OF NORTH CAROLINA INC is the larger business by last-quarter revenue ($21.5M vs $13.8M, roughly 1.6× FENNEC PHARMACEUTICALS INC.). PEOPLES BANCORP OF NORTH CAROLINA INC runs the higher net margin — 30.8% vs -34.7%, a 65.6% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 5.6%). Over the past eight quarters, PEOPLES BANCORP OF NORTH CAROLINA INC's revenue compounded faster (4.2% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
PEOPLES BANCORP OF NORTH CAROLINA INC is a regional bank holding company headquartered in North Carolina, U.S. It offers a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving local residents, small and medium-sized enterprises, and community organizations across its operating areas in North Carolina.
FENC vs PEBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $21.5M |
| Net Profit | $-4.8M | $6.6M |
| Gross Margin | — | — |
| Operating Margin | -18.5% | 40.7% |
| Net Margin | -34.7% | 30.8% |
| Revenue YoY | 73.8% | 5.6% |
| Net Profit YoY | -141.1% | 86.4% |
| EPS (diluted) | $-0.17 | $1.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $21.5M | ||
| Q3 25 | $12.5M | $21.4M | ||
| Q2 25 | $9.7M | $20.7M | ||
| Q1 25 | $8.8M | $20.0M | ||
| Q4 24 | $7.9M | $20.4M | ||
| Q3 24 | $7.0M | $20.5M | ||
| Q2 24 | $7.3M | $20.1M | ||
| Q1 24 | $25.4M | $19.8M |
| Q4 25 | $-4.8M | $6.6M | ||
| Q3 25 | $-638.0K | $3.7M | ||
| Q2 25 | $-3.2M | $5.2M | ||
| Q1 25 | $-1.2M | $4.3M | ||
| Q4 24 | $-2.0M | $3.6M | ||
| Q3 24 | $-5.7M | $4.0M | ||
| Q2 24 | $-5.6M | $4.9M | ||
| Q1 24 | $12.8M | $3.9M |
| Q4 25 | -18.5% | 40.7% | ||
| Q3 25 | -1.5% | 22.4% | ||
| Q2 25 | -28.3% | 32.2% | ||
| Q1 25 | -9.2% | 28.2% | ||
| Q4 24 | -11.8% | 22.5% | ||
| Q3 24 | -74.6% | 26.0% | ||
| Q2 24 | -69.4% | 31.3% | ||
| Q1 24 | 54.2% | 23.9% |
| Q4 25 | -34.7% | 30.8% | ||
| Q3 25 | -5.1% | 17.2% | ||
| Q2 25 | -32.7% | 24.9% | ||
| Q1 25 | -13.3% | 21.8% | ||
| Q4 24 | -25.0% | 17.5% | ||
| Q3 24 | -82.2% | 19.3% | ||
| Q2 24 | -76.5% | 24.4% | ||
| Q1 24 | 50.6% | 19.9% |
| Q4 25 | $-0.17 | $1.21 | ||
| Q3 25 | $-0.02 | $0.67 | ||
| Q2 25 | $-0.11 | $0.95 | ||
| Q1 25 | $-0.04 | $0.79 | ||
| Q4 24 | $-0.02 | $0.65 | ||
| Q3 24 | $-0.21 | $0.72 | ||
| Q2 24 | $-0.20 | $0.89 | ||
| Q1 24 | $0.41 | $0.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $58.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.5M | $157.1M |
| Total Assets | $70.6M | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $58.1M | ||
| Q3 25 | $21.9M | — | ||
| Q2 25 | $18.7M | — | ||
| Q1 25 | $22.7M | — | ||
| Q4 24 | $26.6M | $59.3M | ||
| Q3 24 | $40.3M | $73.2M | ||
| Q2 24 | $43.1M | — | ||
| Q1 24 | $51.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $157.1M | ||
| Q3 25 | $-4.5M | $149.5M | ||
| Q2 25 | $-7.5M | $144.0M | ||
| Q1 25 | $-5.9M | $138.5M | ||
| Q4 24 | $-5.9M | $130.6M | ||
| Q3 24 | $-5.2M | $136.3M | ||
| Q2 24 | $-1.4M | $124.3M | ||
| Q1 24 | $3.0M | $121.1M |
| Q4 25 | $70.6M | $1.7B | ||
| Q3 25 | $49.3M | $1.7B | ||
| Q2 25 | $44.9M | $1.7B | ||
| Q1 25 | $46.4M | $1.7B | ||
| Q4 24 | $44.9M | $1.7B | ||
| Q3 24 | $58.9M | $1.7B | ||
| Q2 24 | $63.2M | $1.7B | ||
| Q1 24 | $69.2M | $1.7B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $21.4M |
| Free Cash FlowOCF − Capex | — | $20.0M |
| FCF MarginFCF / Revenue | — | 92.7% |
| Capex IntensityCapex / Revenue | — | 6.6% |
| Cash ConversionOCF / Net Profit | — | 3.22× |
| TTM Free Cash FlowTrailing 4 quarters | — | $34.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $21.4M | ||
| Q3 25 | $1.5M | $4.7M | ||
| Q2 25 | $-3.7M | $5.5M | ||
| Q1 25 | $-4.3M | $5.9M | ||
| Q4 24 | $-1.5M | $20.6M | ||
| Q3 24 | $-2.2M | $4.9M | ||
| Q2 24 | $-8.4M | $6.7M | ||
| Q1 24 | $39.0M | $3.7M |
| Q4 25 | — | $20.0M | ||
| Q3 25 | — | $4.4M | ||
| Q2 25 | — | $5.4M | ||
| Q1 25 | — | $5.2M | ||
| Q4 24 | — | $20.0M | ||
| Q3 24 | — | $4.7M | ||
| Q2 24 | — | $6.6M | ||
| Q1 24 | — | $3.5M |
| Q4 25 | — | 92.7% | ||
| Q3 25 | — | 20.4% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | — | 25.8% | ||
| Q4 24 | — | 98.0% | ||
| Q3 24 | — | 22.9% | ||
| Q2 24 | — | 32.7% | ||
| Q1 24 | — | 17.9% |
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | 3.22× | ||
| Q3 25 | — | 1.27× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | — | 1.36× | ||
| Q4 24 | — | 5.78× | ||
| Q3 24 | — | 1.24× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | 3.04× | 0.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
